AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitafirst M 100mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Akned Healthcare Pvt. Ltd.

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitafirst M 100mg/500mg Tablet

Diabexe Duo 100mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lessen the risk of cardiovascular events such as heart attack or stroke. Diabexe Duo 100mg/500mg may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily use, at the same time each day, maximizes therapeutic benefit; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle modifications are paramount in diabetes control. Common side effects include nausea, vomiting, diarrhea, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this condition. This medication isn't suitable for all patients. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should seek medical advice. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose throughout treatment.

Uses of Sitafirst M 100mg/500mg Tablet

Treatment of Type 2 diabetes mellitus

Major Benefits of Sitafirst M 100mg/500mg Tablet:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Sitafirst M 100mg/500mg Tablet is to be taken with food.

Common Side effects of Sitafirst M 100mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitafirst M 100mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Sitafirst M 100mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Sitafirst M 100mg/500mg Tablet works:

Sitafirst M 100mg/500mg Tablet is a combination of two medicines: sitagliptin and metformin. Sitagliptin help your pancreas produce more insulin, facilitate effective use of insulin by the body, and reduce excess sugar that your liver makes. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Together, they provide better control of blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitafirst M 100mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitafirst M 100mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitafirst M 100mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitafirst M 100mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitafirst M 100mg/500mg tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitafirst M 100mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Sitafirst M 100mg/500mg Tablet :

If you miss a dose of Sitafirst M 100mg/500mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Facts to Know About Sitafirst M 100mg/500mg Tablet

LabelValue
Addictive None.
Medication Category Medication for diabetes

FAQs on Sitafirst M 100mg/500mg Tablet

A single tablet of Sitafirst M (100mg/500mg) combines sitagliptin and metformin for managing type 2 diabetes in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, promoting increased insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitafirst M 100mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Sitafirst M 100mg/500mg Tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitafirst M 100mg/500mg Tablet constituent or inactive ingredient should not take this medication. Similarly, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitafirst M 100mg/500mg Tablet is unsafe and may heighten the risk of lactic acidosis.
Store the medication in its original, tightly sealed container as directed on the packaging or label. Discard any leftover medication appropriately and ensure it remains inaccessible to children, pets, and others.
Sitagliptin/metformin 100mg/500mg tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this is a rare but significant adverse effect of metformin, prompting its avoidance in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Sitagliptin/metformin immediately and seek urgent medical attention.
A single tablet of Sitafirst M (100mg/500mg) combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a balanced diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under the age of 18.
Sitafirst M 100mg/500mg Tablet may cause common side effects including low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitafirst M 100mg/500mg Tablet ingredient or inactive component should not use this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitafirst M 100mg/500mg Tablet is unsafe due to the heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Sitafirst M 100mg/500mg Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and those consuming substantial alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitafirst M 100mg/500mg Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including peripheral paresthesia (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and ataxia (impaired balance). To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Store the medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
The combined medication Sitafirst M (100mg/500mg) contains sitagliptin and metformin, employed in managing type 2 diabetes mellitus. In adults, it enhances glycemic control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose output and increases insulin sensitivity. Sitagliptin suppresses DPP-4 enzyme activity, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitafirst M 100mg/500mg Tablets may cause frequent side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can also occur. Prolonged use might result in vitamin B12 deficiency.
Individuals with hypersensitivity to any Sitafirst M 100mg/500mg Tablet constituent should not use this medication. Its administration is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitafirst M 100mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Sitafirst M 100mg/500mg tablets. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution, particularly for individuals with impaired kidney function, advanced age, or significant alcohol consumption. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. The occurrence of any of these warrants immediate cessation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitafirst M 100mg/500mg Tablet consumption can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended by some studies at least annually.
Maintain this medication within its original, sealed container. Store as directed on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Sitafirst M 100mg/500mg T...
164
MRP 190
13% off